These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 25468370)

  • 1. Timing underpins the benefits associated with injectable collagen biomaterial therapy for the treatment of myocardial infarction.
    Blackburn NJ; Sofrenovic T; Kuraitis D; Ahmadi A; McNeill B; Deng C; Rayner KJ; Zhong Z; Ruel M; Suuronen EJ
    Biomaterials; 2015 Jan; 39():182-92. PubMed ID: 25468370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Injection of a novel synthetic hydrogel preserves left ventricle function after myocardial infarction.
    Jiang XJ; Wang T; Li XY; Wu DQ; Zheng ZB; Zhang JF; Chen JL; Peng B; Jiang H; Huang C; Zhang XZ
    J Biomed Mater Res A; 2009 Aug; 90(2):472-7. PubMed ID: 18546187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential efficacy of gels derived from small intestinal submucosa as an injectable biomaterial for myocardial infarct repair.
    Okada M; Payne TR; Oshima H; Momoi N; Tobita K; Huard J
    Biomaterials; 2010 Oct; 31(30):7678-83. PubMed ID: 20674011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injectable Citrate-Based Hydrogel as an Angiogenic Biomaterial Improves Cardiac Repair after Myocardial Infarction.
    Yuan Z; Tsou YH; Zhang XQ; Huang S; Yang Y; Gao M; Ho W; Zhao Q; Ye X; Xu X
    ACS Appl Mater Interfaces; 2019 Oct; 11(42):38429-38439. PubMed ID: 31573790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for Mechanisms Underlying the Functional Benefits of a Myocardial Matrix Hydrogel for Post-MI Treatment.
    Wassenaar JW; Gaetani R; Garcia JJ; Braden RL; Luo CG; Huang D; DeMaria AN; Omens JH; Christman KL
    J Am Coll Cardiol; 2016 Mar; 67(9):1074-1086. PubMed ID: 26940929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine.
    Leor J; Tuvia S; Guetta V; Manczur F; Castel D; Willenz U; Petneházy O; Landa N; Feinberg MS; Konen E; Goitein O; Tsur-Gang O; Shaul M; Klapper L; Cohen S
    J Am Coll Cardiol; 2009 Sep; 54(11):1014-23. PubMed ID: 19729119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivering More of an Injectable Human Recombinant Collagen III Hydrogel Does Not Improve Its Therapeutic Efficacy for Treating Myocardial Infarction.
    Pupkaite J; Sedlakova V; Eren Cimenci C; Bak M; McLaughlin S; Ruel M; Alarcon EI; Suuronen EJ
    ACS Biomater Sci Eng; 2020 Jul; 6(7):4256-4265. PubMed ID: 33463355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction.
    Ruvinov E; Leor J; Cohen S
    Biomaterials; 2011 Jan; 32(2):565-78. PubMed ID: 20889201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of integrin α2 in cell and matrix therapy that improves perfusion, viability and function of infarcted myocardium.
    Ahmadi A; McNeill B; Vulesevic B; Kordos M; Mesana L; Thorn S; Renaud JM; Manthorp E; Kuraitis D; Toeg H; Mesana TG; Davis DR; Beanlands RS; DaSilva JN; deKemp RA; Ruel M; Suuronen EJ
    Biomaterials; 2014 Jun; 35(17):4749-58. PubMed ID: 24631247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical properties of poly(N-isopropylacrylamide) hydrogel promote its effects on cardiac protection after myocardial infarction.
    Ren S; Jiang X; Li Z; Wen Y; Chen D; Li X; Zhang X; Zhuo R; Chu H
    J Int Med Res; 2012; 40(6):2167-82. PubMed ID: 23321174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injectable hydrogel therapies and their delivery strategies for treating myocardial infarction.
    Johnson TD; Christman KL
    Expert Opin Drug Deliv; 2013 Jan; 10(1):59-72. PubMed ID: 23140533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of an injectable extracellular matrix hydrogel for treating myocardial infarction.
    Seif-Naraghi SB; Singelyn JM; Salvatore MA; Osborn KG; Wang JJ; Sampat U; Kwan OL; Strachan GM; Wong J; Schup-Magoffin PJ; Braden RL; Bartels K; DeQuach JA; Preul M; Kinsey AM; DeMaria AN; Dib N; Christman KL
    Sci Transl Med; 2013 Feb; 5(173):173ra25. PubMed ID: 23427245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The beneficial effects of deferred delivery on the efficiency of hydrogel therapy post myocardial infarction.
    Kadner K; Dobner S; Franz T; Bezuidenhout D; Sirry MS; Zilla P; Davies NH
    Biomaterials; 2012 Mar; 33(7):2060-6. PubMed ID: 22153866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exogenous miR-29B Delivery Through a Hyaluronan-Based Injectable System Yields Functional Maintenance of the Infarcted Myocardium.
    Monaghan MG; Holeiter M; Brauchle E; Layland SL; Lu Y; Deb A; Pandit A; Nsair A; Schenke-Layland K
    Tissue Eng Part A; 2018 Jan; 24(1-2):57-67. PubMed ID: 28463641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promotion of cardiac differentiation of brown adipose derived stem cells by chitosan hydrogel for repair after myocardial infarction.
    Wang H; Shi J; Wang Y; Yin Y; Wang L; Liu J; Liu Z; Duan C; Zhu P; Wang C
    Biomaterials; 2014 Apr; 35(13):3986-98. PubMed ID: 24508080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catheter-deliverable hydrogel derived from decellularized ventricular extracellular matrix increases endogenous cardiomyocytes and preserves cardiac function post-myocardial infarction.
    Singelyn JM; Sundaramurthy P; Johnson TD; Schup-Magoffin PJ; Hu DP; Faulk DM; Wang J; Mayle KM; Bartels K; Salvatore M; Kinsey AM; Demaria AN; Dib N; Christman KL
    J Am Coll Cardiol; 2012 Feb; 59(8):751-63. PubMed ID: 22340268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of a novel injectable hydrogel implant on ventricular remodeling in rabbits with experimental myocardial infarction].
    Wang T; Jiang XJ; Lin T; Li XY; Zhang JF; Zheng ZB; Chen JL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Feb; 37(2):174-7. PubMed ID: 19720001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Conductive Polymer Hydrogel Supports Cell Electrical Signaling and Improves Cardiac Function After Implantation into Myocardial Infarct.
    Mihic A; Cui Z; Wu J; Vlacic G; Miyagi Y; Li SH; Lu S; Sung HW; Weisel RD; Li RK
    Circulation; 2015 Aug; 132(8):772-84. PubMed ID: 26304669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combined cell therapy and in-situ tissue-engineering approach for myocardial repair.
    Habib M; Shapira-Schweitzer K; Caspi O; Gepstein A; Arbel G; Aronson D; Seliktar D; Gepstein L
    Biomaterials; 2011 Oct; 32(30):7514-23. PubMed ID: 21783246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained Release of a Peptide-Based Matrix Metalloproteinase-2 Inhibitor to Attenuate Adverse Cardiac Remodeling and Improve Cardiac Function Following Myocardial Infarction.
    Fan Z; Fu M; Xu Z; Zhang B; Li Z; Li H; Zhou X; Liu X; Duan Y; Lin PH; Duann P; Xie X; Ma J; Liu Z; Guan J
    Biomacromolecules; 2017 Sep; 18(9):2820-2829. PubMed ID: 28731675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.